Sight Sciences officer proposes $63.8K share sale
The notice says the proposed sale includes an amount needed to cover tax from settlement of a vested equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, Inc. officer James Rodberg gave notice of a proposed sale of 7,208 common shares, for an aggregate market value of $63,813.86, with an approximate sale date of October 2, 2026. The notice identifies restricted stock vesting from the issuer on September 30, 2026; it says the sale includes an amount needed to cover tax from settlement of a vested equity award. Rodberg reported selling 6,902 shares on July 2, 2026, for $36,959.51. Jennifer Ruchti signed as an authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Rodberg.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.